|
|
|
Oxford International, Manchester, UK
27 - 28 Feb 2006
An essential industry update, you will have the opportunity to hear the latest industry case studies, focusing on: • Strategy: Biomarkers as a means of empowering decision-making, reducing costs and increasing productivity • Technologies: Imaging biomarkers and molecular biomarkers • Biomarkers as markers of activity and surrogate endpoints • Regulation: Constraints and challenges • Biomarkers in the preclinical phase • Efficacy models • Metabolomic, genomic and proteomic applications • Clinical validation of biomarkers • Toxicity biomarkers: safety, validation and efficacy testing
|
|
|
|
|
|
Organized by:
|
|
Oxford International |
|
Invited Speakers:
|
|
Confirmed Speakers: **Dr. Allen Roses**, Senior Vice President, Genetics Research, GlaxoSmithKline; **Dr. John Ryan**, Vice President, Experimental Medicine, Wyeth; **Dr. Thomas Henkel**, Vice President, Pharma Research and Development, Bayer HealthCare; **Dr. Richard Hargreaves**, Vice President, Imaging, Merck & Co; **Dr. Rakesh Dixit**, Senior Director, Toxicology, Johnson & Johnson; **Dr. Hakan Wennbo**, Director, Discovery Medicine, Cardiovascular/Gastrointestinal, AstraZeneca; **Dr. Holly Hilton**, Research Informatics, Genetics and Genomics, F. Hoffmann-La Roche; **Dr. Orest Hurko**, Assistant Vice President, Translational Research, Wyeth; **Dr. David Friedman**, Associate Director, Biomarker Technology, Vertex Pharmaceuticals; **Dr. Peter O'Brien**, Head, Discovery Toxicology Biomarkers and Safety Sciences, Pfizer; **Dr. Georg Wensing**, Head, Pharmacodynamics, Clinical Pharmacology, Bayer Healthcare; **Dr. Harsukh Parmar**, Director, Global Discovery Medicine, AstraZeneca; **Dr. Stefan Kass**, Head, Genomic Technologies, Johnson & Johnson; **Dr. Huw Alun Davies**, Manager, UK and Denmark Biomarker Discovery Centers®, Ciphergen; Senior Representative, Oxford Genome Sciences; Senior Representative, Medical Solutions
|
|
|
|
|
|
Deadline for Abstracts:
|
|
20 Dec 2005
|
|
|
|
|
|
Registration:
|
|
For more information and registration details, please email: congressmarketing@oxfordint.co.uk, or call Louisa Carson on: +44 (0) 8701 601 011 quoting HUM-MOLGEN.
|
|
E-mail:
|
|
lcarson@oxfordint.co.uk
|
|
|
|
|
|
|
|